All In Biotech

Drug Trial Radar · NCT06462417

Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis

Study on the Efficacy and Safety of Oral Administration of Arbidol in the Treatment of Allergic Rhinitis Patients

Last checked: Nov 20, 2026Latest source record: May 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Jul 11, 2024

Primary completion

Jun 30, 2025

Study completion Jun 30, 2025

Sponsor

Lead sponsor
Zheng LiuAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Natural Science Foundation of China
First posted
Jun 17, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The most important treatment for AR is topical nasal medications (including nasal corticosteroids, nasal antihistamines, nasal decongestants, and nasal saline irrigation etc.), which are still limited. Arbidol may inhibit molecular targets involved in the pathogenesis of AR. This study intends to explore the effect of Arbidol in the treatment of allergic rhinitis and evaluate its efficacy and safety.

Conditions

  • Allergic Rhinitis

Interventions

  • ArbidolDrug

    Arbidol Hydrochloride Tablets 0.2g/d for 2 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The protein level of molecular biomarkers in nasal epithelial cellsTime frame: 14 days
  2. The mRNA level of inflammation molecular biomarkers in nasal epithelial cellsTime frame: 14 days
  3. The level of inflammation molecular biomarkers in nasal lavage fluidTime frame: 14 days

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology

    Wuhan, Hubei, China · Recruiting

  • Department of ENT, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.